Pamela Irene Hartzband, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Task Performance and Analysis | 2 | 2016 | 771 | 0.780 |
Why?
|
| Efficiency, Organizational | 2 | 2016 | 699 | 0.750 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2020 | 262 | 0.580 |
Why?
|
| Personal Autonomy | 1 | 2020 | 315 | 0.580 |
Why?
|
| Professional Competence | 1 | 2020 | 431 | 0.550 |
Why?
|
| Medicine | 2 | 2012 | 946 | 0.430 |
Why?
|
| Delivery of Health Care | 3 | 2016 | 5367 | 0.390 |
Why?
|
| Burnout, Professional | 1 | 2020 | 712 | 0.370 |
Why?
|
| Vocabulary | 1 | 2011 | 167 | 0.370 |
Why?
|
| Thyroid Nodule | 3 | 2023 | 766 | 0.350 |
Why?
|
| Adenocarcinoma, Follicular | 3 | 2023 | 325 | 0.350 |
Why?
|
| Motivation | 1 | 2020 | 2034 | 0.340 |
Why?
|
| Humanism | 1 | 2009 | 85 | 0.310 |
Why?
|
| Economics, Medical | 1 | 2009 | 112 | 0.310 |
Why?
|
| Electronic Health Records | 2 | 2016 | 4877 | 0.310 |
Why?
|
| Consumer Health Information | 1 | 2010 | 215 | 0.290 |
Why?
|
| Physicians | 2 | 2020 | 4615 | 0.290 |
Why?
|
| Health Care Reform | 2 | 2020 | 1256 | 0.260 |
Why?
|
| Emotions | 1 | 2017 | 2772 | 0.250 |
Why?
|
| Patient Participation | 2 | 2017 | 1450 | 0.250 |
Why?
|
| Culture | 1 | 2009 | 624 | 0.240 |
Why?
|
| Terminology as Topic | 1 | 2012 | 1539 | 0.230 |
Why?
|
| Quality of Health Care | 2 | 2009 | 4340 | 0.220 |
Why?
|
| Hypothyroidism | 2 | 2016 | 670 | 0.220 |
Why?
|
| Decision Making | 1 | 2017 | 3961 | 0.220 |
Why?
|
| Evidence-Based Medicine | 2 | 2012 | 3708 | 0.200 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 2010 | 0.200 |
Why?
|
| Biopsy, Fine-Needle | 3 | 2023 | 1131 | 0.200 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2008 | 1193 | 0.190 |
Why?
|
| User-Computer Interface | 1 | 2008 | 1398 | 0.190 |
Why?
|
| Thyroid Neoplasms | 3 | 2023 | 2360 | 0.190 |
Why?
|
| Carcinoma, Papillary | 2 | 2021 | 792 | 0.190 |
Why?
|
| Iopamidol | 1 | 2001 | 187 | 0.180 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2001 | 129 | 0.170 |
Why?
|
| Early Detection of Cancer | 1 | 2012 | 3230 | 0.150 |
Why?
|
| Hyperparathyroidism | 1 | 1999 | 339 | 0.150 |
Why?
|
| Internet | 1 | 2010 | 3123 | 0.140 |
Why?
|
| Parathyroidectomy | 1 | 1999 | 244 | 0.140 |
Why?
|
| Growth Hormone | 1 | 1997 | 573 | 0.120 |
Why?
|
| Premenopause | 1 | 1999 | 1039 | 0.120 |
Why?
|
| Risk Assessment | 4 | 2023 | 24310 | 0.120 |
Why?
|
| Hypercalcemia | 1 | 1997 | 423 | 0.120 |
Why?
|
| Practice Management, Medical | 1 | 2016 | 191 | 0.110 |
Why?
|
| Treatment Outcome | 3 | 2021 | 65408 | 0.100 |
Why?
|
| Thyroxine | 1 | 2016 | 666 | 0.100 |
Why?
|
| Quality of Life | 1 | 2012 | 13497 | 0.090 |
Why?
|
| Directories as Topic | 1 | 2010 | 8 | 0.090 |
Why?
|
| Hormone Replacement Therapy | 1 | 2016 | 756 | 0.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1997 | 2201 | 0.090 |
Why?
|
| False Positive Reactions | 1 | 2012 | 962 | 0.090 |
Why?
|
| Osteoporosis | 1 | 1999 | 1606 | 0.080 |
Why?
|
| Patient Access to Records | 1 | 2010 | 120 | 0.080 |
Why?
|
| Humans | 29 | 2023 | 768369 | 0.080 |
Why?
|
| Acrylic Resins | 1 | 2009 | 135 | 0.080 |
Why?
|
| Professional Role | 1 | 2011 | 316 | 0.080 |
Why?
|
| Death | 1 | 2012 | 683 | 0.070 |
Why?
|
| Parathyroid Neoplasms | 1 | 2009 | 244 | 0.070 |
Why?
|
| Contrast Media | 1 | 2001 | 5337 | 0.070 |
Why?
|
| Pituitary Diseases | 1 | 1988 | 136 | 0.070 |
Why?
|
| Hypothalamic Diseases | 1 | 1988 | 134 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 3 | 2016 | 7449 | 0.070 |
Why?
|
| Hyperparathyroidism, Primary | 1 | 2009 | 164 | 0.070 |
Why?
|
| Cost Control | 1 | 2009 | 627 | 0.070 |
Why?
|
| Adrenal Insufficiency | 1 | 1988 | 194 | 0.070 |
Why?
|
| Bone Density | 1 | 1999 | 3561 | 0.070 |
Why?
|
| Commerce | 1 | 2011 | 613 | 0.070 |
Why?
|
| ACTH Syndrome, Ectopic | 1 | 2005 | 30 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 8636 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2001 | 4362 | 0.060 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 3484 | 0.060 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 2005 | 61 | 0.060 |
Why?
|
| Thyroglobulin | 1 | 1984 | 111 | 0.060 |
Why?
|
| Tongue Diseases | 1 | 1984 | 69 | 0.060 |
Why?
|
| Clinical Protocols | 1 | 2009 | 1444 | 0.050 |
Why?
|
| Costs and Cost Analysis | 1 | 2009 | 1670 | 0.050 |
Why?
|
| Hydrocortisone | 2 | 2003 | 1836 | 0.050 |
Why?
|
| Prostate-Specific Antigen | 1 | 2012 | 2483 | 0.050 |
Why?
|
| Carcinoma, Small Cell | 1 | 2005 | 420 | 0.050 |
Why?
|
| Octreotide | 1 | 2003 | 155 | 0.050 |
Why?
|
| Benchmarking | 1 | 2009 | 1058 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3116 | 0.050 |
Why?
|
| Language | 1 | 2012 | 1557 | 0.050 |
Why?
|
| Career Choice | 1 | 2009 | 769 | 0.050 |
Why?
|
| Home Care Services | 1 | 2009 | 655 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
| Workload | 1 | 2008 | 852 | 0.050 |
Why?
|
| Cushing Syndrome | 1 | 2003 | 241 | 0.050 |
Why?
|
| Mammography | 1 | 2012 | 2436 | 0.050 |
Why?
|
| Documentation | 1 | 2008 | 913 | 0.050 |
Why?
|
| Somatostatin | 1 | 2003 | 448 | 0.050 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2021 | 85 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8751 | 0.040 |
Why?
|
| Hepatic Artery | 1 | 2001 | 232 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1988 | 1891 | 0.040 |
Why?
|
| Hyperthyroidism | 1 | 1981 | 295 | 0.040 |
Why?
|
| Patient-Centered Care | 1 | 2009 | 1439 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2023 | 614 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 1984 | 1172 | 0.040 |
Why?
|
| Cytodiagnosis | 1 | 2021 | 452 | 0.040 |
Why?
|
| United States | 2 | 2020 | 73120 | 0.040 |
Why?
|
| HIV Wasting Syndrome | 1 | 1997 | 99 | 0.040 |
Why?
|
| Adult | 12 | 2023 | 223528 | 0.030 |
Why?
|
| Physician-Patient Relations | 1 | 2010 | 3267 | 0.030 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 1997 | 327 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2009 | 3266 | 0.030 |
Why?
|
| Female | 10 | 2021 | 396926 | 0.030 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2003 | 1536 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2009 | 3922 | 0.030 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2003 | 619 | 0.030 |
Why?
|
| Male | 10 | 2021 | 364761 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2009 | 3858 | 0.030 |
Why?
|
| Diphosphonates | 1 | 1997 | 635 | 0.030 |
Why?
|
| Prostatic Neoplasms | 2 | 2012 | 11206 | 0.020 |
Why?
|
| Parathyroid Hormone | 1 | 1997 | 1804 | 0.020 |
Why?
|
| Middle Aged | 7 | 2021 | 223406 | 0.020 |
Why?
|
| Cortodoxone | 1 | 1988 | 18 | 0.020 |
Why?
|
| Metyrapone | 1 | 1988 | 22 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2023 | 81835 | 0.020 |
Why?
|
| Acute Disease | 1 | 1999 | 7245 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2021 | 3586 | 0.020 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 1988 | 241 | 0.020 |
Why?
|
| Dehydroepiandrosterone | 1 | 1988 | 259 | 0.020 |
Why?
|
| Deltaretrovirus | 1 | 1985 | 162 | 0.020 |
Why?
|
| Retroviridae Infections | 1 | 1985 | 147 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 21157 | 0.020 |
Why?
|
| Calcium | 1 | 1997 | 5793 | 0.010 |
Why?
|
| Prednisone | 1 | 1988 | 1568 | 0.010 |
Why?
|
| Aldosterone | 1 | 1988 | 874 | 0.010 |
Why?
|
| Vitamin D | 1 | 1997 | 3311 | 0.010 |
Why?
|
| Hormone Antagonists | 1 | 2003 | 107 | 0.010 |
Why?
|
| Calcitonin | 1 | 1984 | 329 | 0.010 |
Why?
|
| Aged | 4 | 2021 | 171514 | 0.010 |
Why?
|
| Proteins | 1 | 1997 | 6009 | 0.010 |
Why?
|
| Carbimazole | 1 | 1981 | 4 | 0.010 |
Why?
|
| Methimazole | 1 | 1981 | 41 | 0.010 |
Why?
|
| Propylthiouracil | 1 | 1981 | 68 | 0.010 |
Why?
|
| Antithyroid Agents | 1 | 1981 | 72 | 0.010 |
Why?
|
| Growth Substances | 1 | 1983 | 761 | 0.010 |
Why?
|
| Goiter | 1 | 1981 | 87 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1984 | 1706 | 0.010 |
Why?
|
| Tongue | 1 | 1984 | 406 | 0.010 |
Why?
|
| Acromegaly | 1 | 1983 | 316 | 0.010 |
Why?
|
| Salivary Gland Neoplasms | 1 | 1984 | 306 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2005 | 13589 | 0.010 |
Why?
|
| Graves Disease | 1 | 1981 | 239 | 0.010 |
Why?
|
| Propranolol | 1 | 1981 | 493 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2003 | 1998 | 0.010 |
Why?
|
| Iodine | 1 | 1981 | 287 | 0.010 |
Why?
|
| Lithium | 1 | 1981 | 600 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1981 | 1035 | 0.010 |
Why?
|
| Cyanates | 1 | 1976 | 22 | 0.010 |
Why?
|
| Neoplasms, Second Primary | 1 | 2005 | 1062 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 59679 | 0.010 |
Why?
|
| Thyroidectomy | 1 | 1981 | 915 | 0.010 |
Why?
|
| Blood Glucose | 1 | 1988 | 6429 | 0.010 |
Why?
|
| Insulin | 1 | 1988 | 6606 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1985 | 3210 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2003 | 2731 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 15638 | 0.010 |
Why?
|
| Leukopenia | 1 | 1985 | 214 | 0.000 |
Why?
|
| Lymphatic Diseases | 1 | 1985 | 320 | 0.000 |
Why?
|
| Dwarfism | 1 | 1983 | 137 | 0.000 |
Why?
|
| Sarcoma, Kaposi | 1 | 1985 | 374 | 0.000 |
Why?
|
| Pregnancy | 1 | 1981 | 30179 | 0.000 |
Why?
|
| Thrombocytopenia | 1 | 1985 | 1183 | 0.000 |
Why?
|
| Syndrome | 1 | 1983 | 3278 | 0.000 |
Why?
|
| Adolescent | 2 | 1983 | 89163 | 0.000 |
Why?
|
| Circular Dichroism | 1 | 1976 | 338 | 0.000 |
Why?
|
| Cell Division | 1 | 1983 | 4479 | 0.000 |
Why?
|
| Oxyhemoglobins | 1 | 1976 | 213 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1976 | 1435 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1983 | 2422 | 0.000 |
Why?
|
| Child | 1 | 1981 | 80856 | 0.000 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1983 | 3408 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1976 | 3972 | 0.000 |
Why?
|
| Binding Sites | 1 | 1976 | 6029 | 0.000 |
Why?
|
| Protein Binding | 1 | 1976 | 9376 | 0.000 |
Why?
|